Bayesian Capital Management’s Xometry XMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,325
Closed -$357K 910
2025
Q1
$357K Buy
+14,325
New +$450K 0.06% 354
2024
Q3
Sell
-17,376
Closed -$201K 1082
2024
Q2
$201K Buy
+17,376
New +$273K 0.02% 611
2023
Q1
Sell
-6,217
Closed -$200K 1133
2022
Q4
$200K Sell
6,217
-4,900
-44% -$229K 0.03% 600
2022
Q3
$631K Buy
+11,117
New +$519K 0.13% 229
2022
Q2
Sell
-19,600
Closed -$720K 1124
2022
Q1
$720K Buy
+19,600
New +$896K 0.11% 277

Other funds holding XMTR

Bayesian Capital Management's XMTR Position: Q2 2025 in Review

Bayesian Capital Management sold out of Xometry (XMTR) in Q2 2025, closing a stake of 14,325 shares — an estimated $357K sold.

Bayesian Capital Management first reported a position in XMTR in Q1 2022 and held it in 5 quarters. The position peaked at $720K in Q1 2022. 192 funds tracked by Wall St. Rank hold XMTR as of Q2 2025.

  • Bayesian Capital Management reported no remaining Xometry position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 14,325 Xometry shares in Q2 2025, an estimated $357K.
  • Bayesian Capital Management first reported a position in Xometry in Q1 2022 and held it in 5 quarters.
  • Bayesian Capital Management's Xometry position peaked at $720K in Q1 2022.
  • 192 funds tracked by Wall St. Rank held Xometry as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.